Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:TFFP

TFF Pharmaceuticals (TFFP) Stock Price, News & Analysis

TFF Pharmaceuticals logo

About TFF Pharmaceuticals Stock (NASDAQ:TFFP)

Advanced Chart

Key Stats

Today's Range
$0.07
$0.07
50-Day Range
$0.07
$0.07
52-Week Range
$0.06
$3.23
Volume
N/A
Average Volume
N/A
Market Capitalization
$288.60 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive TFFP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TFF Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

TFFP Stock News Headlines

TFF Pharmaceuticals approves dissolution plan
$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.
TFF Pharmaceuticals Shares Fall 66%; Company to Wind Down
TFF Pharmaceuticals terminates employees, to wind down operations
TFF Pharmaceuticals to Dissolve and Liquidate Assets
TFF Pharmaceuticals Announces It Will Wind Down Operations
See More Headlines

TFFP Stock Analysis - Frequently Asked Questions

TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) announced its quarterly earnings data on Wednesday, November, 20th. The company reported ($0.81) earnings per share (EPS) for the quarter.

TFF Pharmaceuticals shares reverse split before market open on Tuesday, December 19th 2023.The 1-25 reverse split was announced on Tuesday, December 19th 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, December 19th 2023. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

TFF Pharmaceuticals (TFFP) raised $22 million in an initial public offering (IPO) on Friday, October 25th 2019. The company issued 4,400,000 shares at a price of $5.00 per share. National Securities acted as the underwriter for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that TFF Pharmaceuticals investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), CymaBay Therapeutics (CBAY), GE Aerospace (GE), CrowdStrike (CRWD) and Adobe (ADBE).

Company Calendar

Last Earnings
11/20/2024
Today
8/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:TFFP
CIK
1733413
Fax
N/A
Employees
19
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$730 thousand
Price / Sales
0.40
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.04 per share
Price / Book
0.02

Miscellaneous

Outstanding Shares
4,440,000
Free Float
4,244,000
Market Cap
$288.60 thousand
Optionable
Optionable
Beta
N/A

Social Links

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:TFFP) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners